Elutia (ELUT) Net Equity Issued and Repurchased (2020 - 2025)

Elutia (ELUT) posted Net Equity Issued and Repurchased of $13.8 million for Q1 2025, up 359.87% sequentially from $3.0 million in Q3 2020.

Elutia (ELUT) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Elutia has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $13.8 million in Q1 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $13.8 million in Q1 2025, while the trailing twelve-month figure through Sep 2025 was $13.8 million (up 359.87% YoY) and the FY2020 annual result came in at $3.4 million, up 50.66% from the prior year.
Net Equity Issued and Repurchased climbed to $13.8 million in Q1 2025 per ELUT's latest filing, from $3.0 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $13.8 million in Q1 2025 and troughed at $13.8 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Abbott Laboratories	199.44 Bn	193.84 Bn	7.27 Bn	-
2	Stryker	127.32 Bn	123.85 Bn	4.50 Bn	-
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	97.00 Mn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.90 Bn	47.65 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.36 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.74 Bn	31.63 Bn	2.18 Bn	-
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	-
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn	-
10	Elutia	39.84 Mn	19.94 Mn	1.45 Mn	-

Download Data